Religare Enterprises Ltd (RELIGARE)

IRDAI Slaps Fine on Religare Subsidiary; Cancels Stock Options Granted to Chairperson - 24 Jul, 2024

Religare Enterprises' subsidiary, Care Health Insurance Ltd, has been fined Rs 1 crore by IRDAI and asked to buy back shares allotted to Rashmi Saluja. The cancellation of Saluja's stock options could be a setback for Religare's board in their struggle against the Burman family for control of the financial services company.

Religare Control Dispute Intensifies as Burmans Trigger Open Offer - 23 Jul, 2024

The Burman family has acquired a 25% ownership stake in Religare Enterprises, triggering the need for an open offer. Meanwhile, IRDAI has ordered Care Health Insurance to cancel stock options worth Rs. 250 crore issued to Saluja amid the ongoing dispute over Religare's control.

Religare Enterprises Ltd to Benefit from Upcoming Budget - 21 Jul, 2024

According to Dr Ravi Singh, SVP - Retail Research at Religare Broking, the upcoming budget is expected to extend the good run of the stock market. The government's increase in capital expenditure and policy continuation are likely to benefit sectors such as defence, infrastructure, and PSUs, which could positively impact Religare Enterprises Ltd.

Corporate Battle and Allegations Against Religare Board - 19 Jul, 2024

The Burman family is engaged in a corporate battle with the board of Religare Enterprises Ltd over alleged governance lapses. Markets regulator Sebi has ordered an open offer application. Meanwhile, Religare's Executive Chairperson Rashmi Saluja defends against the allegations and emphasizes that the company has only grown stronger since the one-time settlement.

Controversy Over Stock Options May Delay Burman Family's Bid for Religare Enterprises - 15 Jul, 2024

The controversy over Care Health Insurance Ltd's award of hefty stock options to its chairperson Rashmi Saluja may further delay the billionaire Burman family's bid to take over the company's parent entity, Religare Enterprises Ltd.

Religare Directed to Comply with SEBI Order on Open Offer - 11 Jul, 2024

The Securities Appellate Tribunal has directed Religare Enterprises to comply with SEBI's order and seek necessary regulatory approvals for the Burman family's open offer. The company has been exempted from coercive action until August 29, 2024.

SEBI Directs Religare to Comply with Open Offer Directive - 10 Jul, 2024

The Securities Appellate Tribunal has directed Religare Enterprises to comply with the SEBI directive, clearing the path for the Burman family to increase their stake in the company. The appellate tribunal stayed the show cause notice issued to the company and its board. This decision stems from an SEBI order dated June 19, which mandated that Religare provide an undertaking within seven days.

Religare Finvest CEO Seeks Measures to Reduce Financing Costs for MSMEs - 09 Jul, 2024

Pankaj Sharma, CEO of Religare Finvest Ltd, has called for measures to reduce financing costs for MSMEs through interest rate subsidies, easier access to credit, and tax relief and incentives for innovation.

Religare Enterprises Expects Union Budget to Foster Innovation and Financial Inclusion - 05 Jul, 2024

Executive Chairperson of Religare Enterprises, Rashmi Saluja, expects the Union Budget 2024-25 to encourage innovation, financial inclusion, and adoption of cutting-edge technologies like blockchain and AI. This will attract international investments and democratize financial services.

Religare Enterprises Witnesses Stake Sale and Acquisition - 02 Jul, 2024

Plutus Wealth Management has sold a 2% stake in Religare Enterprises for Rs 170 crore, while Societe General has acquired a 1.53% stake. The company's FY24 revenues rose by 33.2%, but net profits decreased by 89% YoY.

Plutus Sells Stake in Religare to Societe Generale - 01 Jul, 2024

Plutus Wealth Management has sold a 2% stake in Religare Enterprises for Rs 170 crore, reducing its shareholding to 3.97%. Meanwhile, Societe Generale bought 50.5 lakh shares at an average price of Rs 239 per share.